Detalhe da pesquisa
1.
A descriptive cost-analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high-dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma.
Eur J Haematol
; 107(3): 333-342, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34053112
2.
Effect of PET/CT on the Management and Outcomes of Participants with Hodgkin and Aggressive Non-Hodgkin Lymphoma: A Multicenter Registry.
Radiology
; 290(2): 488-495, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30511907
3.
Transfusion Camp: a prospective evaluation of a transfusion education program for multispecialty postgraduate trainees.
Transfusion
; 59(6): 2141-2149, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30946497
4.
[18 F]-FDG PET/CT in the staging and management of indolent lymphoma: A prospective multicenter PET registry study.
Cancer
; 123(15): 2860-2866, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28295218
5.
Chemotherapy alone vs. chemotherapy plus radiotherapy in female adolescent and young adults with Hodgkin's lymphoma: reproductive health outcomes.
J Cancer Surviv
; 2023 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37148406
6.
Canadian real-world experience of asciminib treatment in heavily pre-treated chronic myeloid leukemia (CML) patients who failed multiple lines of tyrosine kinase inhibitor (TKI) therapy.
Leuk Res
; 133: 107374, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37657146
7.
Acquired hemophilia A presenting post partum.
CMAJ
; 177(4): 339-40, 2007 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-17698819